
@RaajitRampal @MSKCancerCenter @MSK_DeptOfMed @pankitvachhani @mpdrc Thanks Raajit for you commitment to MPN patients and pelabresib! Hope you are well!
English
Jigar Raythatha
55 posts










We’re excited to announce the closing of a $105 million financing round to advance our product pipeline, including initiation of multiple Phase 2 studies of our allosteric TYK2 inhibitor in 2021 and 2022. Read more: bit.ly/3hASlHF






















